| Attribute |
Value |
| 52 Week Change |
0.24594402 |
| Address1 |
500 Plaza Drive |
| All Time High |
219.2 |
| All Time Low |
3.3125 |
| Ask |
0.0 |
| Ask Size |
100 |
| Audit Risk |
7 |
| Average Analyst Rating |
2.2 - Buy |
| Average Daily Volume10 Day |
781,170 |
| Average Daily Volume3 Month |
911,495 |
| Average Volume |
911,495 |
| Average Volume10Days |
781,170 |
| Beta |
0.571 |
| Bid |
0.0 |
| Bid Size |
200 |
| Board Risk |
7 |
| Book Value |
66.36 |
| City |
Secaucus |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Compensation Risk |
2 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
207.35 |
| Current Ratio |
1.179 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,782,777,600 |
| Day High |
210.7196 |
| Day Low |
207.01 |
| Debt To Equity |
82.737 |
| Dividend Date |
1,784,678,400 |
| Dividend Rate |
3.44 |
| Dividend Yield |
1.66 |
| Earnings Call Timestamp End |
1,784,836,800 |
| Earnings Call Timestamp Start |
1,784,836,800 |
| Earnings Growth |
0.155 |
| Earnings Quarterly Growth |
0.145 |
| Earnings Timestamp |
1,784,809,800 |
| Earnings Timestamp End |
1,784,809,800 |
| Earnings Timestamp Start |
1,784,809,800 |
| Ebitda |
2,225,999,872 |
| Ebitda Margins |
0.19738 |
| Enterprise To Ebitda |
13.184 |
| Enterprise To Revenue |
2.602 |
| Enterprise Value |
29,346,904,064 |
| Eps Current Year |
10.76897 |
| Eps Forward |
11.67129 |
| Eps Trailing Twelve Months |
9.04 |
| Esg Populated |
0 |
| Ex Dividend Date |
1,783,468,800 |
| Exchange |
NYQ |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
198.5994 |
| Fifty Day Average Change |
8.75061 |
| Fifty Day Average Change Percent |
0.044061616 |
| Fifty Two Week Change Percent |
24.594402 |
| Fifty Two Week High |
219.2 |
| Fifty Two Week High Change |
-11.849991 |
| Fifty Two Week High Change Percent |
-0.05406018 |
| Fifty Two Week Low |
164.65 |
| Fifty Two Week Low Change |
42.700012 |
| Fifty Two Week Low Change Percent |
0.25933808 |
| Fifty Two Week Range |
164.65 - 219.2 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
850,833,000,000 |
| Five Year Avg Dividend Yield |
1.85 |
| Float Shares |
110,128,556 |
| Forward Eps |
11.67129 |
| Forward P E |
17.765818 |
| Free Cashflow |
947,875,008 |
| Full Exchange Name |
NYSE |
| Full Time Employees |
57,000 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Governance Epoch Date |
1,782,864,000 |
| Gross Margins |
0.33277 |
| Gross Profits |
3,752,999,936 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.00426 |
| Held Percent Institutions |
0.98042 |
| Implied Shares Outstanding |
110,696,429 |
| Industry |
Diagnostics & Research |
| Industry Disp |
Diagnostics & Research |
| Industry Key |
diagnostics-research |
| Ir Website |
http://ir.questdiagnostics.com/phoenix.zhtml?c=82068&p=irol-stockquote |
| Is Earnings Date Estimate |
0 |
| Language |
en-US |
| Last Dividend Date |
1,783,468,800 |
| Last Dividend Value |
0.86 |
| Last Fiscal Year End |
1,767,139,200 |
| Last Split Date |
1,119,312,000 |
| Last Split Factor |
2:1 |
| Long Business Summary |
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey. |
| Long Name |
Quest Diagnostics Incorporated |
| Market |
us_market |
| Market Cap |
22,952,906,752 |
| Market State |
PRE |
| Max Age |
86,400 |
| Message Board Id |
finmb_361335 |
| Most Recent Quarter |
1,774,915,200 |
| Net Income To Common |
1,020,000,000 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
22,952,904,553 |
| Number Of Analyst Opinions |
16 |
| Open |
207.48 |
| Operating Cashflow |
1,850,000,000 |
| Operating Margins |
0.14197 |
| Overall Risk |
3 |
| Payout Ratio |
0.36020002 |
| Peg Ratio |
1.6 |
| Phone |
973 520 2700 |
| Pre Market Change |
-2.3600006 |
| Pre Market Change Percent |
-1.1381724 |
| Pre Market Price |
204.99 |
| Pre Market Time |
1,784,030,703 |
| Previous Close |
207.44 |
| Price Eps Current Year |
19.254396 |
| Price Hint |
2 |
| Price To Book |
3.1246233 |
| Price To Sales Trailing12 Months |
2.035193 |
| Profit Margins |
0.0908 |
| Quick Ratio |
0.91 |
| Quote Type |
EQUITY |
| Recommendation Key |
buy |
| Recommendation Mean |
2.16667 |
| Region |
US |
| Regular Market Change |
-0.0899963 |
| Regular Market Change Percent |
-0.0433843 |
| Regular Market Day High |
210.7196 |
| Regular Market Day Low |
207.01 |
| Regular Market Day Range |
207.01 - 210.7196 |
| Regular Market Open |
207.48 |
| Regular Market Previous Close |
207.44 |
| Regular Market Price |
207.35 |
| Regular Market Time |
1,783,972,803 |
| Regular Market Volume |
415,540 |
| Return On Assets |
0.06348 |
| Return On Equity |
0.14538999 |
| Revenue Growth |
0.092 |
| Revenue Per Share |
101.833 |
| Sand P52 Week Change |
0.20365608 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Share Holder Rights Risk |
2 |
| Shares Outstanding |
110,696,429 |
| Shares Percent Shares Out |
0.0337 |
| Shares Short |
3,732,507 |
| Shares Short Previous Month Date |
1,780,012,800 |
| Shares Short Prior Month |
3,430,849 |
| Short Name |
Quest Diagnostics Incorporated |
| Short Percent Of Float |
0.033800002 |
| Short Ratio |
4.23 |
| Source Interval |
15 |
| State |
NJ |
| Symbol |
DGX |
| Target High Price |
245.0 |
| Target Low Price |
184.0 |
| Target Mean Price |
223.6875 |
| Target Median Price |
225.0 |
| Total Cash |
393,000,000 |
| Total Cash Per Share |
3.55 |
| Total Debt |
6,408,000,000 |
| Total Revenue |
11,278,000,128 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
3.26 |
| Trailing Annual Dividend Yield |
0.015715387 |
| Trailing Eps |
9.04 |
| Trailing P E |
22.936947 |
| Trailing Peg Ratio |
1.5963 |
| Triggerable |
1 |
| Two Hundred Day Average |
191.51524 |
| Two Hundred Day Average Change |
15.834763 |
| Two Hundred Day Average Change Percent |
0.08268148 |
| Type Disp |
Equity |
| Volume |
415,540 |
| Website |
https://www.questdiagnostics.com |
| Zip |
7,094 |